HONG KONG: The Shanghai stock benchmark retreated from a fresh 10-year high to close lower on Tuesday, as investors rotated into undervalued sectors following a blistering rally. The Shanghai ... ( read original story ...)
Moves afoot to stifle vicious competition
In response, regulators have pushed banks to resist harmful competition. Industrial and Commercial Bank of China, the country's largest State-owned commercial lender, has made eliminating ... ( read original story ...)
China Stocks Back To Market Leadership, But This Could Derail Them
A sublayer of stocks in the consumer, financial, electric vehicle and other industries displays bullish charts. ( read original story ...)
AI Chipmaker Iluvatar CoreX Is Said to Mull Hong Kong IPO
Iluvatar CoreX is considering an initial public offering in Hong Kong, as investor interest in Chinese artificial intelligence chipmakers builds with Beijing discouraging local firms from using Nvidia ... ( read original story ...)
China Thematic Update: New IPOs, Healthcare Momentum From Regulatory Reprieve And Innovation, New Hydroelectric Dam
China's re-rating this year, driven by stimulus measures and policy reforms, could lead to increased global flows to the country's equity market. Click to read. ( read original story ...)
Shanghai Fosun Pharma Renews Financial Services Agreement with Fosun Finance
Co ( (HK:2196) ) has provided an update. Shanghai Fosun Pharmaceutical has renewed its Financial Services Agreement with Fosun Finance for three years starting January 2026. This agreement, which ... ( read original story ...)
China Citic Bank raises $5.4 billion in HK and Shanghai IPO
China's eighth-largest lender raised $3.67 billion from its Hong Kong IPO after pricing the 4.885 billion shares offered at HK$5.86 ($0.75) each, near the high end of its indicative range, the ... ( read original story ...)